PLTR sits at $189.82, pinned against its Bollinger upper band with momentum flat-lining and smart money running net short — yet Rosenblatt's fresh $225 Buy target and a 93% Q2 revenue beat give bul...

PLTR is trading at $189.82 as of the September 24 open, up 2.3% over the last 24 hours but finishing well off the session high of $193.86. That failure to hold the day's top matters. The stock is essentially kissing its Bollinger upper band — currently sitting at $189.94 — which means buyers are absorbing supply right at a statistical resistance ceiling. When price hugs the upper band this tightly with a %B of 0.9959, it is not a breakout signal; it is a warning that the move is exhausted until proven otherwise.

The backdrop driving this tension is real and material. In Q2 2026, Palantir delivered $1.94 billion in total revenue — up 92.8% year-over-year — crushing the $1.81 billion consensus estimate. U.S. commercial revenue surged 149%, and U.S. government revenue jumped 90% to $809 million. The company also booked a record $2.13 billion in U.S. commercial contract value in a single quarter. That is not hype; that is one of the strongest fundamental quarters any large-cap software company has printed in years. For macro context and market reaction to these numbers, Blockchain.news has been tracking the AI-sector wave driving institutional capital into enterprise software names with defensible government revenue floors.

The overhang, however, is the NHS Federated Data Platform contract — a deal worth up to £330 million ($447 million) over seven years — where British lobbyists are pushing the government to trigger a break clause ahead of the February 2027 review date.

Source link